Predictive Value of HLA‐Derived T‐Cell Epitope and B‐Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Zakieh Zare und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Pancreas Transplantation, Graft Rejection, Algorithms, Epitopes, T-Lymphocyte. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Donor/recipient HLA molecular mismatches are predictive of kidney transplant outcomes. Their role in pancreas transplantation has not been well studied.
Methods
We conducted a retrospective cohort study in 281 pancreas (± kidney) transplant recipients during 2000–2018, followed for average 53.8 months. T‐cell epitope matching was performed by the PIRCHE‐II algorithm (T2) and B‐cell epitope mismatch using Snow (B2) and HLA Matchmaker algorithms. Primary outcome was pancreas acute rejection, secondary outcomes included pancreas graft failure and composite of both, and kidney graft failure.
Results
PIRCHE‐T2 score (59.3±22.3) was not associated with study outcomes (HR 0.99, 95%CI 0.98–1.00, p = 0.31 for pancreas rejection). However, increasing PIRCHE‐B score (15.1±6.3) was predictive of lower risk of acute rejection (aHR 0.94; 95%CI 0.9–0.99, p = 0.024) and graft failure (aHR 0.96; 95%CI 0.93–0.99; p = 0.021), driven by PIRCHE‐B‐Class II score (aHR 0.91; 95%CI 0.85–0.98, p = 0.01; aHR 0.92; 95%CI 0.88–0.97; p = 0.001, respectively). Total eplet mismatch (19.58±7.40) was highly correlated with PIRCHE‐B score (ρ = 0.82, p < 0.0001), showing similar associations. However, the molecular scores were not associated with kidney graft failure ( p > 0.57 for all).
Conclusion
Our study suggests that higher B‐cell epitope mismatch loads are paradoxically associated with improved pancreas transplant outcomes, while PIRCHE‐T2 scores demonstrated limited predictive value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- PIRCHE, Berlin, Germany.
- Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
- Transplant Diagnostics, Thermo Fisher Scientific, Waltham, Massachusetts, USA.
- Division of Transplant Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Zitieren
APA
Zare, Z., Niemann, M., Shirini, K., Booth, I., Dale, B., Ugarte, R., Niederhaus, S. V., Drachenberg, C. B., & Haririan, A. (2026). Predictive Value of HLA‐Derived T‐Cell Epitope and B‐Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes. Clinical Transplantation. https://doi.org/10.1111/ctr.70677
Vancouver
Zare Z, Niemann M, Shirini K, Booth I, Dale B, Ugarte R, et al. Predictive Value of HLA‐Derived T‐Cell Epitope and B‐Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes. Clinical Transplantation. 2026. doi:10.1111/ctr.70677
BibTeX
@article{Zare2026,
author = {Zare, Zakieh and Niemann, Matthias and Shirini, Kasra and Booth, Ian and Dale, Bethany and Ugarte, Richard and Niederhaus, Silke V and Drachenberg, Cinthia B and Haririan, Abdolreza},
title = {Predictive Value of HLA‐Derived T‐Cell Epitope and B‐Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70677}
}
EUVIMED